1)Nathan H, et al:Trends in survival after surgery for cholangiocarcinoma:a 30-year population-based SEER database analysis. J Gastrointest Surg 11:1488-1496, 2007
2)Miyazaki M, et al:Combined vascular resection in operative resection for hilar cholangiocarcinoma:does it work or not? Surgery 141:581-588, 2007
3)Nagino M, et al:Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma:an audit of 50 consecutive cases. Ann Surg 252:115-123, 2010
4)胆道癌診療ガイドライン作成出版委員会(編):胆道癌診療ガイドライン[第一版].医学図書出版,2007
5)Takada T, et al:Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase Ⅲ multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95:1685-1695, 2002
6)Oettle H, et al:Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer:a randomized controlled trial. JAMA 297:267-277, 2007
7)Valle J, et al:Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273-1281, 2010
8)Okusaka T, et al:Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer:a comparative multicentre study in Japan. Br J Cancer 103:469-474, 2010
9)Raderer M, et al:Two consecutive phase Ⅱ studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer. Oncology 56:177-180, 1999
10)Penz M, et al:Phase Ⅱ trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 12:183-186, 2001
11)Lin MH, et al:A phase Ⅱ trial of gemcitabine in the treatment of advanced bile duct and periamullary carcinomas. Chemotherapy 49:154-158, 2003
12)Furuse J, et al:S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer:a multicenter phase Ⅱ study. Cancer Chemother Pharmacol 62:849-855, 2008
13)Sudo K, et al:Phase Ⅱ study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer. Cancer Chemother Pharmacol 67:249-254, 2011
14)Brus C, Saif MW:Second line therapy for advanced pancreatic adenocarcinoma:where are we and where are we going? Highlights from the“2010 ASCO Annual Meeting”. Chicago, IL, USA. June 4-8, 2010. JOP 11:321-323, 2010
15)Nakamura K, et al:Phase Ⅱ trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer. Br J Cancer 94:1575-1579, 2006
16)Takashima A, et al:Randomized phase Ⅱ study of gemcitabine plus S-1 combination therapy vs. S-1 in advanced biliary tract cancer:Japan Clinical Oncology Group Study(JCOG0805). Jpn J Clin Oncol 40:1189-1191, 2010
17)Murakami Y, et al:Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 18:651-658, 2011